SK bioscience Advances RSV Antibody Clinical Development
Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...
Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...
Irvine, Calif., July 27, 2026 Masimo, a Danaher company and global leader in patient monitoring technologies, has received U.S....
